Stochastic cost-effectiveness analysis on population benefits

被引:0
|
作者
Ermo Chen
机构
[1] Peking University,School of Mathematical Sciences
关键词
Stochastic cost-effectiveness analysis; Population benefits; Risk allocation; Return on risk;
D O I
暂无
中图分类号
学科分类号
摘要
Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of population benefits, concerning the benefits of a group of individuals but not just a typical one. This paper proposes a stochastic CEA tool that supports medical decision-making from the perspective of population benefits of risk and return, the risk-adjusted incremental cost-effectiveness ratio (ICER). The tool has a traditional form of ICER but uses the cost under a risk-adjusted expectation. Theoretically, we prove that the tool can provide medical decisions trimming that promote the risk-return level on population benefits within any intervention structure and can also serve as a criterion for the optimal intervention structure. Numerical simulations within a framework of mean–variance support the conclusions in this paper.
引用
收藏
相关论文
共 50 条
  • [31] Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population
    Dinh, Tuan A.
    Rosner, Benjamin I.
    Atwood, James C.
    Boland, C. Richard
    Syngal, Sapna
    Vasen, Hans F. A.
    Gruber, Stephen B.
    Burt, Randall W.
    CANCER PREVENTION RESEARCH, 2011, 4 (01) : 9 - 22
  • [32] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF HEALTH-CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1988, 18 (01): : 1 - 9
  • [33] Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
    Bambha, K
    Kim, WR
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (06) : 519 - 526
  • [34] Bayesian cost-effectiveness analysis with two measures of effectiveness:: the cost-effectiveness acceptability plane
    Negrín, MA
    Vázquez-Polo, FJ
    HEALTH ECONOMICS, 2006, 15 (04) : 363 - 372
  • [35] Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: A cost-effectiveness analysis
    Cadish, L. A.
    Shepherd, J. P.
    Barber, E. L.
    Ridgeway, B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (03) : S568 - S568
  • [36] Statistical cost-effectiveness analysis of two treatments based on net health benefits
    Laska, EM
    Meisner, M
    Siegel, C
    Wanderling, J
    STATISTICS IN MEDICINE, 2001, 20 (08) : 1279 - 1302
  • [37] Using Cost-Effectiveness Analysis to Define a Breast Cancer Benefits Package for the Uninsured
    Jennifer L. Malin
    Emmett Keeler
    Cynthia Wang
    Robert Brook
    Breast Cancer Research and Treatment, 2002, 74 : 143 - 153
  • [38] Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured
    Malin, JL
    Keeler, E
    Wang, C
    Brook, R
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (02) : 143 - 153
  • [39] HEALTH BENEFITS AND COST-EFFECTIVENESS ANALYSIS OF EARLY CERVICAL CANCER DIAGNOSIS IN BULGARIA
    Slavchev, G.
    Dacheva, A.
    Vutova, Y.
    Djambazov, S.
    VALUE IN HEALTH, 2023, 26 (12) : S153 - S153
  • [40] Burdens and benefits of placebos in antidepressant clinical trials: A decision and cost-effectiveness analysis
    Kim, SYH
    Holloway, RG
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07): : 1272 - 1276